Financial markets
Biotech Acquisition Company Announces Separation of Class A Ordinary Shares and Warrants
Biotech Acquisition Company, a blank check company, has announced that holders of its initial public offering units can elect to separately trade the Company's Class A ordinary shares and warrants, commencing March 18, 2021. The separation of units will result in the Class A Ordinary Shares and warrants